Search

everythinglearnresearchcommunity

for

Search:↓

Black ethnicity, prior PSA tests, enlarged prostate, and family history increase prostate cancer risk; Asian ethnicity, obesity, smoking, diabetes, and less sexual activity or no children decrease risk.

Finasteride for hair loss is safe and does not increase the risk of high-grade prostate cancer.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Men who experienced baldness at age 20 may have double the risk of getting prostate cancer.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

The document concludes that the 5 alpha-reductase enzymes are important in steroid metabolism and related to various human diseases, with inhibitors used to treat conditions like male pattern baldness and prostate issues.

Using a single PSA level to decide on a prostate biopsy is not effective; a more personalized approach considering various factors is recommended.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Early-onset baldness is linked to a higher risk of aggressive prostate cancer in African-American men, especially before age 60.

Physical activity, height, and smoking affect prostate cancer risk.

Men with more advanced male pattern baldness have a higher risk of prostate cancer and more severe disease.

Men with early hair loss may have a higher risk of enlarged prostate and possibly prostate cancer due to shared hormonal factors.

Serum triglyceride levels are not linked to prostate cancer risk.

Men with baldness at the front and top of their head at age 45 may have a higher risk of aggressive prostate cancer.

5α-reductase inhibitors may prevent prostate cancer but could also raise the risk of more severe cancers.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

Some natural compounds may help overcome drug resistance in certain cancers, but more research is needed.

Men with male pattern baldness have a higher risk of dying from prostate cancer.

Finasteride might lower the risk of low-grade prostate cancer but not high-grade cancer, while alpha-blockers might reduce high-grade cancer risk.

Men with a certain baldness pattern at age 40-50 may have a higher risk of aggressive prostate cancer.

Baldness in men with prostate cancer is linked to higher levels of certain sex hormones, but chest hair density is not.

Finasteride reduces prostate cancer risk but may increase high-grade tumors and has side effects; biopsy methods have similar outcomes; psychosocial factors affect sexual recovery post-surgery.

Medical castration in prostate cancer patients can increase the risk of serious heart rhythm problems, so it's important to monitor heart activity during treatment.

The document suggests more research is needed to understand the link between baldness and prostate cancer.

A49T gene variant linked to higher prostate cancer risk, lower hormone levels, and slightly reduced balding risk.

Men with vertex baldness may have a higher risk of developing prostate cancer, but more research is needed to confirm this.

Finasteride treats hair loss and reduces prostate cancer risk.